Theseus Pharmaceuticals Statistics
Total Valuation
Blend Labs has a market cap or net worth of $707.95 million. The enterprise value is $622.03 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Blend Labs has 259.32 million shares outstanding. The number of shares has increased by 3.06% in one year.
| Current Share Class | 255.70M |
| Shares Outstanding | 259.32M |
| Shares Change (YoY) | +3.06% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 5.74% |
| Owned by Institutions (%) | 55.41% |
| Float | 220.40M |
Valuation Ratios
The trailing PE ratio is 0.24 and the forward PE ratio is 36.02. Blend Labs's PEG ratio is 1.80.
| PE Ratio | 0.24 |
| Forward PE | 36.02 |
| PS Ratio | 4.19 |
| Forward PS | 4.18 |
| PB Ratio | 5.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 61.50 |
| PEG Ratio | 1.80 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.21 |
| EV / Sales | 3.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.40 |
| Quick Ratio | 1.98 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.40% and return on invested capital (ROIC) is -9.26%.
| Return on Equity (ROE) | -10.40% |
| Return on Assets (ROA) | -6.96% |
| Return on Invested Capital (ROIC) | -9.26% |
| Return on Capital Employed (ROCE) | -15.74% |
| Revenue Per Employee | $310,696 |
| Profits Per Employee | $5.49M |
| Employee Count | 540 |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Blend Labs has paid $108,000 in taxes.
| Income Tax | 108,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.25% in the last 52 weeks. The beta is 1.25, so Blend Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +2.25% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 29.19 |
| Average Volume (20 Days) | 2,261,062 |
Short Selling Information
The latest short interest is 8.20 million, so 3.16% of the outstanding shares have been sold short.
| Short Interest | 8.20M |
| Short Previous Month | 7.90M |
| Short % of Shares Out | 3.16% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 4.21 |
Income Statement
In the last 12 months, Blend Labs had revenue of $167.78 million and earned $2.96 billion in profits. Earnings per share was $11.51.
| Revenue | 167.78M |
| Gross Profit | 96.43M |
| Operating Income | -20.52M |
| Pretax Income | -112.09M |
| Net Income | 2.96B |
| EBITDA | -18.31M |
| EBIT | -20.52M |
| Earnings Per Share (EPS) | $11.51 |
Full Income StatementBalance Sheet
The company has $88.30 million in cash and $2.38 million in debt, giving a net cash position of $85.92 million or $0.33 per share.
| Cash & Cash Equivalents | 88.30M |
| Total Debt | 2.38M |
| Net Cash | 85.92M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 127.68M |
| Book Value Per Share | -0.09 |
| Working Capital | 74.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $11.51 million and capital expenditures -$14.35 million, giving a free cash flow of -$2.82 million.
| Operating Cash Flow | 11.51M |
| Capital Expenditures | -14.35M |
| Free Cash Flow | -2.82M |
| FCF Per Share | -$0.01 |
Full Cash Flow StatementMargins
Gross margin is 57.47%, with operating and profit margins of -12.23% and -11.51%.
| Gross Margin | 57.47% |
| Operating Margin | -12.23% |
| Pretax Margin | -8.14% |
| Profit Margin | -11.51% |
| EBITDA Margin | -10.91% |
| EBIT Margin | -12.23% |
| FCF Margin | n/a |
Dividends & Yields
Blend Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.06% |
| Shareholder Yield | -3.06% |
| Earnings Yield | 418.68% |
| FCF Yield | -0.40% |
Analyst Forecast
The average price target for Blend Labs is $4.88, which is 78.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.88 |
| Price Target Difference | 78.76% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Blend Labs has an Altman Z-Score of 0.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.48 |
| Piotroski F-Score | 4 |
